The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses

Aim: To investigate the role of diffusion weighted magnetic resonance imaging (MRI) in differentiation of benign and malignant breast lesions using apparent diffusion coefficient (ADC) values preoperatively. Methods: A total of 30 women between the ages of 14-75 years (mean, 47, 6 years) with 30 his...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Biomedical Research 2020-01, Vol.3 (1), p.37-46
Hauptverfasser: Ozturk, Emine, Yucesoy, Cuneyt, Ozbalci, Gokhan Selcuk, Seker, Gaye Ebru, Ozbalci, Aysu Basak
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim: To investigate the role of diffusion weighted magnetic resonance imaging (MRI) in differentiation of benign and malignant breast lesions using apparent diffusion coefficient (ADC) values preoperatively. Methods: A total of 30 women between the ages of 14-75 years (mean, 47, 6 years) with 30 histopathologically verified breast lesions were investigated in this study. The patients were examined by a 1, 5 T MRI device using bilateral phased array breast coil. Spin echo planar diffusion imaging was used to scan patients. Images were obtained by b values 0 and 500 seconds/[mm.sup.2] Mean ADC values of the benign and malignant lesions were measured and calculated. The comparison between the histopathological diagnoses and the mean ADCs were performed by Mann Whitney U test. Results: The diagnosis of 30 patients with 30 breast lesions were as follows; malign lesions (n=13), benign lesions (n=17). The ADC values were as follows (in units of [10.sup.-3][mm.sup.2]/sec): benign breast lesions (range: 1, 09-1, 98, mean: 1, 45) and malignant breast lesions (range: 0, 59-1, 08, mean: 0, 76). The mean ADC obtained from malignant breast lesions was statistically different from that observed in benign solid lesions (p
ISSN:2618-6454
2618-6454
DOI:10.30714/j-ebr.2020157452